SCHEMBL2945562

SCHEMBL2945562

CCN(CC)CC#CC(C)C

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.53
CHRM4 P08173 3/20 0.53
CHRM5 P08912 3/20 0.53
CHRM1 P11229 3/20 0.53
CHRM3 P20309 3/20 0.53
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 1/20 0.36
KCNH2 Q12809 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPY2R P49146 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26402885 0.82 CHRM2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL1647893 0.80 CHRM2 (0.55) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12590734 0.78
SCHEMBL13005301 0.77 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL10257125 0.76 CHRM2 (0.59) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12793995 0.75 ALDH1A1 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL17407569 0.72 CHRM2 (0.45) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL27324722 0.70 MEN1 (0.32) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL31605942 0.70 CHRM2 (0.46) CHRM2CHRM4CHRM5CHRM1CHRM3
Isobutane SCHEMBL28239716 0.69 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090208576-A1 Orally Disintegrating Tablets RUBICON RESEARCH PRIVATE LIMITED (IN) 2009-08-20 US claimed
EP-2001450-A2 DIRECTLY COMPRESSIBLE COMPOSITE FOR ORALLY DISINTEGRATING TABLETS Rubicon Research Private Limited (IN) 2008-12-17 EP claimed
WO-2007113856-A2 DIRECTLY COMPRESSIBLE COMPOSITE FOR ORALLY DISINTEGRATING TABLETS RUBICON RESEARCH PRIVATE LIMITED (IN) 2007-10-11 WO claimed
EP-0580860-B1 METHOD OF MANUFACTURING SOLID DISPERSION NIPPON SHINYAKU CO LTD (JP) 1997-10-22 EP claimed
WO-2023018648-A1 PHENOL DERIVATIVES FOR USE IN THE MODULATION OF BRM GENENTECH, INC. (US) 2023-02-16 WO disclosed
EP-2001450-B1 DIRECTLY COMPRESSIBLE COMPOSITE FOR ORALLY DISINTEGRATING TABLETS RUBICON RES PRIVATE LIMITED (IN) 2019-01-30 EP disclosed
EP-1660050-B1 Ibuprofen-containing fast dissolving tablet WYETH LLC (US) 2016-11-23 EP disclosed
US-20140249190-A1 Fast Dissolving Tablet WYETH LLC (US) 2014-09-04 US disclosed
CN-101460150-B Directly compressible compound for orally disintegrating tablets RUBICON RES PRIVATE LTD 2014-02-12 CN disclosed
US-8580305-B2 Tablet quickly melting in oral cavity NIPPON SHINYAKU CO., LTD. (JP) 2013-11-12 US disclosed
US-20130296385-A1 Fast Dissolving Tablet WYETH LLC (US) 2013-11-07 US disclosed
US-8545890-B2 Orally disintegrating tablets RUBICON RESEARCH PRIVATE LIMITED (IN) 2013-10-01 US disclosed
EP-0497977-B1 GASTRIC PREPARATION NIPPON SHINYAKU CO LTD (JP) 1995-03-15 EP disclosed
EP-0627218-A1 FAST SOLUBLE TABLET NIPPON SHINYAKU COMPANY, LIMITED (JP) 1994-12-07 EP disclosed
US-5368861-A Gastric preparation with sustained release NIPPON SHINYAKU CO., LTD. (JP) 1994-11-29 US disclosed
EP-0580861-A1 CAPSULE NIPPON SHINYAKU COMPANY, LIMITED (JP) 1994-02-02 EP disclosed
EP-0580860-A1 METHOD OF MANUFACTURING SOLID DISPERSION NIPPON SHINYAKU COMPANY, LIMITED (JP) 1994-02-02 EP disclosed
EP-0497977-A1 GASTRIC PREPARATION NIPPON SHINYAKU COMPANY, LIMITED (JP) 1992-08-12 EP disclosed
CN-1041582-A BUTYNELAMINE DERIVATIVE NIPPON SHINYAKU CO LTD (JP) 1990-04-25 CN disclosed
EP-0359311-A2 Butynylamine derivatives NIPPON SHINYAKU COMPANY, LIMITED (JP) 1990-03-21 EP disclosed